FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013238974> ?p ?o ?g. }

• W2013238974 endingPage "1230" @default.
• W2013238974 startingPage "1225" @default.
• W2013238974 abstract "Early and adequate risk stratification is essential in patients with suspected acute coronary syndrome (ACS). The aim of the present study was to investigate whether glycogen phosphorylase BB (GPBB) could add prognostic information in the context of contemporary sensitive troponin I determination and B-type natriuretic peptide (BNP). Patients with suspected ACS were consecutively enrolled at 3 German study centers from January 2007 through December 2008. Troponin I, GPBB, and BNP were determined at admission. Follow-up information on the combined end point of death, myocardial infarction, revascularization, and hospitalization owing to a cardiovascular cause was obtained 6 months after enrollment. In total 1,818 patients (66% men) were enrolled of whom 413 (23%) were diagnosed as having acute myocardial infarction and 240 (13%) as having unstable angina pectoris, whereas in 1,165 patients (64%) an ACS could be excluded. Follow-up information was available in 98% of patients; 203 events were registered. GPBB measured on admission predicted an unfavorable outcome with a hazard ratio of 1.24 (p <0.05) in an unadjusted Cox regression model and showed a tendency with a hazard ratio of 1.13 (p = 0.07) in a fully adjusted model. Kaplan–Meier analysis revealed a poorer outcome in patients with increased GPBB levels amendatory to the information provided by troponin I or BNP. In conclusion, GPBB measurement provides predictive information on midterm prognosis in patients with chest pain in addition to BNP and troponin I. Early and adequate risk stratification is essential in patients with suspected acute coronary syndrome (ACS). The aim of the present study was to investigate whether glycogen phosphorylase BB (GPBB) could add prognostic information in the context of contemporary sensitive troponin I determination and B-type natriuretic peptide (BNP). Patients with suspected ACS were consecutively enrolled at 3 German study centers from January 2007 through December 2008. Troponin I, GPBB, and BNP were determined at admission. Follow-up information on the combined end point of death, myocardial infarction, revascularization, and hospitalization owing to a cardiovascular cause was obtained 6 months after enrollment. In total 1,818 patients (66% men) were enrolled of whom 413 (23%) were diagnosed as having acute myocardial infarction and 240 (13%) as having unstable angina pectoris, whereas in 1,165 patients (64%) an ACS could be excluded. Follow-up information was available in 98% of patients; 203 events were registered. GPBB measured on admission predicted an unfavorable outcome with a hazard ratio of 1.24 (p <0.05) in an unadjusted Cox regression model and showed a tendency with a hazard ratio of 1.13 (p = 0.07) in a fully adjusted model. Kaplan–Meier analysis revealed a poorer outcome in patients with increased GPBB levels amendatory to the information provided by troponin I or BNP. In conclusion, GPBB measurement provides predictive information on midterm prognosis in patients with chest pain in addition to BNP and troponin I." @default.
• W2013238974 created "2016-06-24" @default.
• W2013238974 creator A5011685634 @default.
• W2013238974 creator A5021000995 @default.
• W2013238974 creator A5022358930 @default.
• W2013238974 creator A5030454575 @default.
• W2013238974 creator A5030999965 @default.
• W2013238974 creator A5035254382 @default.
• W2013238974 creator A5046127730 @default.
• W2013238974 creator A5053048440 @default.
• W2013238974 creator A5056680652 @default.
• W2013238974 creator A5058117590 @default.
• W2013238974 creator A5059435519 @default.
• W2013238974 creator A5064540641 @default.
• W2013238974 creator A5074580088 @default.
• W2013238974 creator A5075174977 @default.
• W2013238974 date "2012-11-01" @default.
• W2013238974 modified "2023-09-27" @default.
• W2013238974 title "Prognostic Information of Glycogen Phosphorylase Isoenzyme BB in Patients With Suspected Acute Coronary Syndrome" @default.
• W2013238974 cites W1555724679 @default.
• W2013238974 cites W1560575497 @default.
• W2013238974 cites W1988254771 @default.
• W2013238974 cites W2002625745 @default.
• W2013238974 cites W2022296599 @default.
• W2013238974 cites W2025257872 @default.
• W2013238974 cites W2095133069 @default.
• W2013238974 cites W2095605519 @default.
• W2013238974 cites W2126384336 @default.
• W2013238974 cites W2126830306 @default.
• W2013238974 cites W2132393613 @default.
• W2013238974 cites W2138195718 @default.
• W2013238974 cites W2154555604 @default.
• W2013238974 cites W2167105972 @default.
• W2013238974 cites W2169735148 @default.
• W2013238974 cites W2172202899 @default.
• W2013238974 doi "https://doi.org/10.1016/j.amjcard.2012.06.020" @default.
• W2013238974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22818785" @default.
• W2013238974 hasPublicationYear "2012" @default.
• W2013238974 type Work @default.
• W2013238974 sameAs 2013238974 @default.
• W2013238974 citedByCount "12" @default.
• W2013238974 countsByYear W20132389742013 @default.
• W2013238974 countsByYear W20132389742015 @default.
• W2013238974 countsByYear W20132389742018 @default.
• W2013238974 countsByYear W20132389742020 @default.
• W2013238974 countsByYear W20132389742021 @default.
• W2013238974 countsByYear W20132389742022 @default.
• W2013238974 countsByYear W20132389742023 @default.
• W2013238974 crossrefType "journal-article" @default.
• W2013238974 hasAuthorship W2013238974A5011685634 @default.
• W2013238974 hasAuthorship W2013238974A5021000995 @default.
• W2013238974 hasAuthorship W2013238974A5022358930 @default.
• W2013238974 hasAuthorship W2013238974A5030454575 @default.
• W2013238974 hasAuthorship W2013238974A5030999965 @default.
• W2013238974 hasAuthorship W2013238974A5035254382 @default.
• W2013238974 hasAuthorship W2013238974A5046127730 @default.
• W2013238974 hasAuthorship W2013238974A5053048440 @default.
• W2013238974 hasAuthorship W2013238974A5056680652 @default.
• W2013238974 hasAuthorship W2013238974A5058117590 @default.
• W2013238974 hasAuthorship W2013238974A5059435519 @default.
• W2013238974 hasAuthorship W2013238974A5064540641 @default.
• W2013238974 hasAuthorship W2013238974A5074580088 @default.
• W2013238974 hasAuthorship W2013238974A5075174977 @default.
• W2013238974 hasConcept C126322002 @default.
• W2013238974 hasConcept C144469398 @default.
• W2013238974 hasConcept C164705383 @default.
• W2013238974 hasConcept C207103383 @default.
• W2013238974 hasConcept C2777698277 @default.
• W2013238974 hasConcept C2777785093 @default.
• W2013238974 hasConcept C2778704086 @default.
• W2013238974 hasConcept C36036425 @default.
• W2013238974 hasConcept C44249647 @default.
• W2013238974 hasConcept C500558357 @default.
• W2013238974 hasConcept C50382708 @default.
• W2013238974 hasConcept C71924100 @default.
• W2013238974 hasConceptScore W2013238974C126322002 @default.
• W2013238974 hasConceptScore W2013238974C144469398 @default.
• W2013238974 hasConceptScore W2013238974C164705383 @default.
• W2013238974 hasConceptScore W2013238974C207103383 @default.
• W2013238974 hasConceptScore W2013238974C2777698277 @default.
• W2013238974 hasConceptScore W2013238974C2777785093 @default.
• W2013238974 hasConceptScore W2013238974C2778704086 @default.
• W2013238974 hasConceptScore W2013238974C36036425 @default.
• W2013238974 hasConceptScore W2013238974C44249647 @default.
• W2013238974 hasConceptScore W2013238974C500558357 @default.
• W2013238974 hasConceptScore W2013238974C50382708 @default.
• W2013238974 hasConceptScore W2013238974C71924100 @default.
• W2013238974 hasIssue "9" @default.
• W2013238974 hasLocation W20132389741 @default.
• W2013238974 hasLocation W20132389742 @default.
• W2013238974 hasOpenAccess W2013238974 @default.
• W2013238974 hasPrimaryLocation W20132389741 @default.
• W2013238974 hasRelatedWork W2045631116 @default.
• W2013238974 hasRelatedWork W2058968015 @default.
• W2013238974 hasRelatedWork W2070626630 @default.
• W2013238974 hasRelatedWork W2084401989 @default.
• W2013238974 hasRelatedWork W2106094931 @default.
• W2013238974 hasRelatedWork W2115768769 @default.

• next